Casper Pharma Llc
1 products tracked · names used in filings: Casper Pharma Llc
Upcoming milestones
No upcoming milestones listed.
Recent milestones
Tue 02 Jun 2026🇺🇸 FDA approval
FDA approves Tiocystin (tiopronin): new formulation or manufacturer
Casper Pharma Llc; NDA212927; New formulation or manufacturer; tablet · source
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇺🇸 | Tiocystin tiopronin | Approved | 2026-06-02 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.